CHRISTINA TANAKA: Open Payments
NPI 1710331889 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 71 payments from 17 companies in 2025. Trend: 2023 $1,174 · 2024 $711 · 2025 $1,655
Food & beverage: $1,621Education: $34
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $254 |
| GENZYME CORPORATION | 8 | $222 |
| Genentech USA, Inc. | 8 | $172 |
| GlaxoSmithKline, LLC. | 7 | $136 |
| W. L. Gore & Associates, Inc. | 1 | $131 |
| CSL Behring | 6 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $126 |
| PFIZER INC. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Amgen Inc. | 3 | $74 |
Products named: DUPIXENT, Xolair, Rhapsido, EXCLUDER Conformable AAA Endoprosthesis with Active Control, NUCALA, Andembry, AIRSUPRA, CUVITRU.
Industry payments across FL — which companies pay providers there.
